Keyphrases
Rifapentine
100%
Cost Barriers
100%
Activism
100%
Tuberculosis Research
100%
Research Innovation
100%
United States
28%
Tuberculosis
28%
Sanofi
28%
Drug Companies
28%
Recent Advances
14%
Treatment Options
14%
Potential Barrier
14%
Positive Impact
14%
Civil Society
14%
Survey Respondent
14%
Survey Results
14%
Underutilization
14%
Public Health Programs
14%
Survey Response
14%
Barriers to Use
14%
Collaborative Efforts
14%
Advocacy Strategies
14%
Access to Treatment
14%
U.S. Public Health
14%
Developing Tools
14%
Blister Pack
14%
Secure Access
14%
Computer Science
And-States
100%
Survey Response
100%
Survey Respondent
100%
Pharmacology, Toxicology and Pharmaceutical Science
Rifapentine
100%
Base
14%
Tablet
14%
Blister
14%
Agricultural and Biological Sciences